Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]

spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

Dicot Pharma has secured approximately SEK 231M (€21M) in gross [...]

Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

Cidara Therapeutics’ investigational long-acting antiviral, CD388, has achieved statistically significant [...]